Integrins and integrin-related proteins in cardiac fibrosis
- PMID: 26562414
- PMCID: PMC4846493
- DOI: 10.1016/j.yjmcc.2015.11.010
Integrins and integrin-related proteins in cardiac fibrosis
Abstract
Cardiac fibrosis is one of the major components of the healing mechanism following any injury of the heart and as such may contribute to both systolic and diastolic dysfunction in a range of pathophysiologic conditions. Canonically, it can occur as part of the remodeling process that occurs following myocardial infarction or that follows as a response to pressure overload. Integrins are cell surface receptors which act in both cellular adhesion and signaling. Most importantly, in the context of the continuously contracting myocardium, they are recognized as mechanotransducers. They have been implicated in the development of fibrosis in several organs, including the heart. This review will focus on the involvement of integrins and integrin-related proteins, in cardiac fibrosis, outlining the roles of these proteins in the fibrotic responses in specific cardiac pathologies, discuss some of the common end effectors (angiotensin II, transforming growth factor beta 1 and mechanical stress) through which integrins function and finally discuss how manipulation of this set of proteins may lead to new treatments which could prove useful to alter the deleterious effects of cardiac fibrosis.
Keywords: Angiotensin; Fibrosis; Integrins; Mechanical stress; Myocardium; Transforming growth factor beta.
Published by Elsevier Ltd.
Figures
Similar articles
-
Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling.Cells. 2021 Mar 31;10(4):770. doi: 10.3390/cells10040770. Cells. 2021. PMID: 33807373 Free PMC article. Review.
-
Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.Circ Heart Fail. 2015 Jul;8(4):788-98. doi: 10.1161/CIRCHEARTFAILURE.114.001963. Epub 2015 May 18. Circ Heart Fail. 2015. PMID: 25985794 Free PMC article.
-
Angiotensin II, adhesion, and cardiac fibrosis.Cardiovasc Res. 2000 May;46(2):264-8. doi: 10.1016/s0008-6363(00)00044-4. Cardiovasc Res. 2000. PMID: 10773230 Review.
-
Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.J Am Coll Cardiol. 2004 May 5;43(9):1698-705. doi: 10.1016/j.jacc.2003.11.058. J Am Coll Cardiol. 2004. PMID: 15120833
-
Syndecans in heart fibrosis.Cell Tissue Res. 2016 Sep;365(3):539-52. doi: 10.1007/s00441-016-2454-2. Epub 2016 Jul 14. Cell Tissue Res. 2016. PMID: 27411689 Review.
Cited by
-
Effects of emodin, a plant-derived anthraquinone, on TGF-β1-induced cardiac fibroblast activation and function.J Cell Physiol. 2021 Nov;236(11):7440-7449. doi: 10.1002/jcp.30416. Epub 2021 May 27. J Cell Physiol. 2021. PMID: 34041746 Free PMC article.
-
Cardiac Fibrosis: Key Role of Integrins in Cardiac Homeostasis and Remodeling.Cells. 2021 Mar 31;10(4):770. doi: 10.3390/cells10040770. Cells. 2021. PMID: 33807373 Free PMC article. Review.
-
Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.Int J Cardiol. 2018 Nov 1;270:228-236. doi: 10.1016/j.ijcard.2018.06.061. Epub 2018 Jun 21. Int J Cardiol. 2018. PMID: 30220377 Free PMC article.
-
Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification.Heart Fail Rev. 2018 Sep;23(5):789-799. doi: 10.1007/s10741-018-9694-z. Heart Fail Rev. 2018. PMID: 29607455 Review.
-
Blocking protein phosphatase 2A signaling prevents endothelial-to-mesenchymal transition and renal fibrosis: a peptide-based drug therapy.Sci Rep. 2016 Jan 25;6:19821. doi: 10.1038/srep19821. Sci Rep. 2016. PMID: 26805394 Free PMC article.
References
-
- Miner EC, Miller WL. A look between the cardiomyocytes: the extracellular matrix in heart failure. Mayo Clin Proc. 2006;81:71–76. - PubMed
-
- Nanthakumar CB, Hatley RJ, Lemma S, Gauldie J, Marshall RP, Macdonald SJ. Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nat Rev Drug Discov. 2015 - PubMed
-
- Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013;10:15–26. - PubMed
-
- Ambale-Venkatesh B, Lima JA. Cardiac MRI: a central prognostic tool in myocardial fibrosis. Nat Rev Cardiol. 2015;12:18–29. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources